Name:
Institution:
Type:
PI
Grant Award Details
Cellular Immune Tolerance Symposium
Grant Type:
Grant Number:
EDUC1-14681
Project Objective:
- On May 4th, 2023 Stanford is hosting a one day "Cellular Immunotherapy Symposia". One of the major obstacles to the implementation of stem cell therapies is overcoming allogeneic immune rejection which is a major topic of discussion of the symposium. Different strategies to overcome this barrier will be presented, including the use of hematopoietic mixed chimerism, T regulatory cell populations, immune shielding by removing MHC or other immune molecules and other approaches. In addition, stem cell therapies themselves can be used for inducing immune tolerance including hematopoietic mixed chimerism, and stem-cell like T regulatory cell and immune cell therapies. Stem cell therapies for a number of diseases will be discussed including organ and islet transplantation, Type 1 diabetes, multiple sclerosis, rheumatoid arthritis, pemphigus, scleroderma, GAD65 disease, among others.
Investigator:
Disease Focus:
Beta Thalassemia
Blood Disorders
Bone Marrow Transplant and Viral Infection
Diabetes
Genetic Disorder
Immune Disease
Kidney Disease
Kidney Failure
Metabolic Disorders
Multiple Sclerosis
Neurological Disorders
Sickle Cell Disease
Type 1 diabetes
Award Value:
$32,751
Status:
Active
Grant Application Details
Application Title:
- Cellular Immune Tolerance Symposium
Public Abstract:
Statement of Benefit to California:
